




Please contact the doctor's office to verify that your insurance is accepted.
Fellowship: Hematology/Oncology at New York Presbyterian Hospital, 1997-2000
Residency: New York Presbyterian Hospital, 1995-97
Internship: The Beth Israel Hospital, Boston 1994-95
Medical School: The Mount Sinai School of Medicine, New York, 1994
Undergraduate: Yale University, 1990
Oral Drug Combo Effective for Older Patients With Acute Myeloid Leukemia
In "Left on Tenth," Writer Delia Ephron Brings Her Cancer Journey to the Stage
Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
Olutasidenib Alone or in Combination With Azacitidine as a Bridge to Transplant in Relapsed/Refractory mIDH1 AML.